Health report: the challenge of cleaving proteins in the membrane by Fluhrer, Regina
The concept of proteolysis wasfirst discovered in 1836, whenTheodor Schwann, a German
researcher, purified pepsin as an
enzyme capable of fragmenting nutri-
ent proteins in the intestine. Peptide
bonds, the chemical bonds that connect
amino acids within a protein, are very
stable and hydrolysis, the breakage with
water, is not easy. This is important
because it allows, for instance, that we
can shower in the morning without our
skin dissolving. However, it is a hurdle
if it comes to degradation and, thus,
cleavage of these bonds, since energy,
the so-called activation energy, needs
to be invested. Here, proteases come
into play: with their special active site,
also known as the catalytic centre,
they interact with their substrates
forcing them into a special confirma-
tion that reduces the activation
energy allowing hydrolysis of peptide
bonds within milliseconds that with-
out this catalysis would take hundreds
of years and life wouldn’t be possible.
To date, more than 500 human 
proteases, with specificity for an even
greater number of substrates are
known. However, the vast majority of
these proteases are soluble proteins
that are active in an aqueous environ-
ment within cells and tissues or in
body fluids like blood.
In 1997, more than 150 years after the
discovery of the first protease, it
became evident that proteolysis also
occurs within cellular membranes.
Membranes of cells are composed of
lipids that arrange as bilayer to 
separate the inner of a cell from its
surroundings, but also allowing a lim-
ited and very selective permeability,
particularly for small molecules. To
allow passage of larger or charged
molecules, like glucose and certain
ions and to enable cells to communi-
cate with their environment, various
proteins are integrated into cellular
membranes. 
Many of these proteins span the mem-
brane with domains that are mainly
composed of amino acids that allow
interaction with lipids. These proteins
are termed integral membrane pro-
teins. Like all cellular proteins, integral
membrane proteins are subject to a
permanent turnover that requires de
novo synthesis and subsequent degra-
dation. Protein degradation requires
proteases since they are the only 
players in a cell capable of hydrolysing
peptide bonds. 
Proteases capable of cleaving peptide
bonds in membrane-embedded pro-
tein domains, face specific difficulties
compared to proteases cleaving 
soluble proteins: i) the peptide bonds
in their substrates are embedded in
lipids and thus access of the protease
to its substrate is much more difficult
than in solution. ii) lipid-embedded
protein domains tend to form ordered
helical structures, which again 
aggravates cleavage. iii) water, critical
for hydrolysis, is much less abundant
in membranes. iv) diffusion rates in
lipid environment differ from that 
in solution.
Remarkably, despite these additional
challenges, intramembrane proteases
apply similar catalytic strategies as
their soluble cousins. Based on the
amino acids or co-factors critical for
catalysis in their active centre four
major classes of intramembrane 
proteases have been identified: 
metallo, serine, glutamyl and aspartyl
intramembrane proteases. 
The peculiarity of these proteases is
that their active site, like the cleavage
site in their substrates, localises to
domains embedded in the cellular
membrane. In addition, intramem-
brane proteases comprise further
membrane-spanning domains that
allow the formation of a pore-like
structure in the lipid environment.
Thus, intramembrane proteases com-
bine protease features with that of
transporters and channels as they are,
for instance, used to carry glucose or
sodium ions over membranes. Their
membrane-spanning domains allow
contact with the integral membrane
domains of their substrates and most
likely by a lateral opening of the 
pore-like structure the substrate gains
access to the protease active site. This
structural layout also allows access of
water molecules so that proteolysis
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can take place. Although the mecha-
nism of the actual peptide bond
hydrolysis is similar to that observed
for soluble proteases, kinetics of 
substrate recognition and cleavage by
intramembrane proteases seems to
be fundamentally different and are far
from being completely understood.
“Remarkably, despite these additional
challenges, intramembrane proteases
apply similar catalytic strategies as
their soluble cousins. Based on the
amino acids or co-factors critical for
catalysis in their active centre four
major classes of intramembrane
proteases have been identified:
metallo, serine, glutamyl and aspartyl
intramembrane proteases.” 
Cleavage of integral membrane 
proteins by intramembrane proteases
liberates protein fragments on both
sides of the membrane. Thus,
intramembrane proteases not only
initiate degradation of membrane
proteins but also produce protein
fragments that are capable of trans-
mitting signals across membranes. In
that context, S2P, a metallo intramem-
brane protease, has been linked to
the regulation of cholesterol synthesis,
SPPL3, an aspartyl intramembrane
protease to the regulation of protein
glycosylation and various intramem-
brane proteases contribute to cell 
differentiation (read more in the 
January 2019 edition of Open Access
Government). 
Moreover, intramembrane proteases
contribute to the proper function of
the immune system (read more in the
April 2019 edition of Open Access 
Government) and are implicated in the
development of neurodegenerative
diseases (read more in the July 2019
edition of Open Access Government),
cancer and infectious diseases (read
more in the October 2019 edition of
Open Access Government). 
Compared to soluble proteases,
which have become important and
valuable targets for treatment and
prevention of human diseases, like
HIV infections, high blood pressure or
stroke, intramembrane proteases are
only known for a short period of time.
To utilise intramembrane proteases in
the future as targets to treat or even
cure diseases, it is indispensable to
understand their cleavage mecha-
nisms, substrate repertoires and phys-
iological function in depth. Therefore,
much more basic research on these
fascinating enzymes will be required
to raise this treasure.
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